KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Inventory: 2010-2022

Historic Inventory for TherapeuticsMD (TXMD) over the last 7 years, with Sep 2022 value amounting to $6.7 million.

  • TherapeuticsMD's Inventory fell 8.98% to $6.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $6.7 million, marking a year-over-year decrease of 8.98%. This contributed to the annual value of $7.6 million for FY2021, which is 4.64% down from last year.
  • TherapeuticsMD's Inventory amounted to $6.7 million in Q3 2022, which was up 8.96% from $6.2 million recorded in Q2 2022.
  • TherapeuticsMD's 5-year Inventory high stood at $14.6 million for Q1 2020, and its period low was $1.6 million during Q1 2018.
  • For the 3-year period, TherapeuticsMD's Inventory averaged around $8.4 million, with its median value being $7.6 million (2021).
  • In the last 5 years, TherapeuticsMD's Inventory soared by 342.89% in 2019 and then slumped by 49.71% in 2021.
  • Over the past 5 years, TherapeuticsMD's Inventory (Quarterly) stood at $3.3 million in 2018, then skyrocketed by 262.97% to $11.9 million in 2019, then plummeted by 32.61% to $8.0 million in 2020, then decreased by 4.64% to $7.6 million in 2021, then fell by 8.98% to $6.7 million in 2022.
  • Its Inventory stands at $6.7 million for Q3 2022, versus $6.2 million for Q2 2022 and $9.0 million for Q1 2022.